Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Clinicopathologic features of advanced squamous NSCLC
Lung cancer remains the leading cause of cancer-related death worldwide. NSCLC
accounts for more than 85% of all lung cancers, and the prognosis for advanced-stage …
accounts for more than 85% of all lung cancers, and the prognosis for advanced-stage …
Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
CA Jiménez-Ruiz, S Andreas… - European …, 2015 - publications.ersnet.org
Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary
tuberculosis are common pulmonary diseases that are caused or worsened by tobacco …
tuberculosis are common pulmonary diseases that are caused or worsened by tobacco …
Smoking cessation after cancer diagnosis and enhanced therapy response: mechanisms and significance
S Chellappan - Current Oncology, 2022 - mdpi.com
The adverse effects of smoking on human health have been recognized for several
decades, especially in the context of cancer. The ability of tobacco smoke components …
decades, especially in the context of cancer. The ability of tobacco smoke components …
[HTML][HTML] Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy
A Koch, H Fohlin, S Sörenson - Journal of thoracic oncology, 2009 - Elsevier
Hypothesis The objective of the study was to analyze if C-reactive protein (CRP) and
smoking status provide prognostic information in patients with advanced non-small cell lung …
smoking status provide prognostic information in patients with advanced non-small cell lung …
Impact of smoking on lung cancer treatment effectiveness: a review
A Condoluci, C Mazzara, A Zoccoli, A Pezzuto… - Future …, 2016 - Taylor & Francis
Tobacco smoke contains more than 4000 detectable substances, such as polycyclic
aromatic hydrocarbons, nicotine, carbon monoxide and heavy metals, which are considered …
aromatic hydrocarbons, nicotine, carbon monoxide and heavy metals, which are considered …
A bupropion smoking cessation clinical trial for cancer patients
RA Schnoll, E Martinez, KL Tatum, DM Weber… - Cancer Causes & …, 2010 - Springer
Objective Many cancer patients continue to smoke post diagnosis, yet there have been few
smoking cessation trials for this population. Depression, which is prevalent among cancer …
smoking cessation trials for this population. Depression, which is prevalent among cancer …
National cancer institute conference on treating tobacco dependence at cancer centers
National Cancer Institute Conference on Treating Tobacco Dependence at Cancer Centers |
JCO Oncology Practice Skip to main content ASCO Publications Publications Journal of Clinical …
JCO Oncology Practice Skip to main content ASCO Publications Publications Journal of Clinical …
Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review
Background Small-cell lung cancer (SCLC) accounts for 12–15% of lung cancers and is
associated with poor survival outcomes and high symptom burden. This study employed a …
associated with poor survival outcomes and high symptom burden. This study employed a …
Smoking cessation in lung cancer—achievable and effective
S Andreas, A Rittmeyer… - Deutsches Ärzteblatt …, 2013 - pmc.ncbi.nlm.nih.gov
Background Lung cancer is the leading cause of death from cancer in Germany. 90% of
cases are due to the inhalation of tobacco smoke. About 40% of patients with newly …
cases are due to the inhalation of tobacco smoke. About 40% of patients with newly …
A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive‐disease small cell lung cancer
JY Han, KY Lim, SY Yu, T Yun, HT Kim, JS Lee - Cancer, 2011 - Wiley Online Library
BACKGROUND: The objective of this study was to investigate the efficacy of simvastatin in
combination with irinotecan and cisplatin in chemotherapy‐naive patients with extensive …
combination with irinotecan and cisplatin in chemotherapy‐naive patients with extensive …